Lexaurin

Bromazepam, the active ingredient in Lexaurin, is a benzodiazepine presented as an oral tablet for oral use. It is prescribed for anxiety disorders and provides short‑term relief of anxiety in adult patients and may be used in clinical settings requiring rapid anxiolysis under medical supervision.

GNH USA supplies Lexaurin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution. Customers benefit from reliable logistics and responsive technical support throughout the supply chain.

Bromazepam acts on the central nervous system to alleviate anxiety-related conditions.

- Anxiety disorders: reduces excessive worry and tension, improving daily functioning. - Short‑term relief of anxiety: provides rapid symptom control during acute episodes. - Preoperative anxiety: calms patients before surgical procedures, facilitating cooperation. - Panic attacks (acute): may be employed for short‑term management of isolated panic episodes. - Adjustment disorder with anxiety: helps mitigate heightened stress responses during life changes.

Bromazepam may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Drowsiness - Fatigue - Dizziness - Impaired coordination

Serious or Rare Side Effects: - Respiratory depression - Severe allergic reaction (e.g., rash, swelling, anaphylaxis)

When prescribing bromazepam, clinicians should consider several safety measures to minimize risk.

- Assess renal and hepatic function: adjust use in patients with severe impairment. - Avoid abrupt discontinuation: taper under medical supervision to prevent withdrawal. - Monitor for signs of dependence: use only short term and reassess regularly. - Caution in elderly: increased sensitivity to sedation and falls. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Bromazepam can interact with other substances that affect the central nervous system or drug metabolism.

Major Interactions (Avoid): - Alcohol: additive CNS depression leading to profound sedation. - Opioids: combined effect may cause respiratory depression. - Other benzodiazepines: cumulative sedation and increased overdose risk.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may enhance sedative effect. - Antihistamines: can increase drowsiness and impair alertness.